rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jane H. Hollingsworth

Director

Company insider

Files Form 4 as: Director, CervoMed; Chief Executive Officer, Nupathe.

Every Form 4 they filed

In numbers

Trades disclosed
35
Buys
2
Sells
0
Bought
$71K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
11 Aug 2010
Last trade
8 Jun 2026
Last filed
10 Jun 2026

Companies traded

Where they are an officer
NupatheDirector, Officer · last 8 Mar 20121 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CRVO CervoMedDirector · Biotechnology · last 8 Jun 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 10 Jun 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,150 at $0.00filing
8 Jun 2026filed 10 Jun 2026CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,150 at $0.00filing
23 Jun 2025filed 25 Jun 2025CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—8,100 at $0.00filing
14 Jun 2024filed 14 Jun 2024CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—5,750 at $0.00filing
15 Sep 2023filed 15 Sep 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code A—6,450 at $0.00filing
31 Aug 2023filed 6 Sep 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code M—122 at $0.00filing
31 Aug 2023filed 6 Sep 2023CRVO CervoMedBiotechnologySEC FORM 4 Code M—122filing
31 Aug 2023filed 6 Sep 2023CRVO CervoMedBiotechnologySEC FORM 4 Code D—45filing
31 May 2023filed 2 Jun 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code M—183 at $0.00filing
31 May 2023filed 2 Jun 2023CRVO CervoMedBiotechnologySEC FORM 4 Code M—183filing
31 May 2023filed 2 Jun 2023CRVO CervoMedBiotechnologySEC FORM 4 Code D—68filing
28 Feb 2023filed 3 Mar 2023CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code M—183 at $0.00filing
28 Feb 2023filed 3 Mar 2023CRVO CervoMedBiotechnologySEC FORM 4 Code M—183filing
28 Feb 2023filed 3 Mar 2023CRVO CervoMedBiotechnologySEC FORM 4 Code D—68filing
30 Nov 2022filed 2 Dec 2022CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code M—183 at $0.00filing
30 Nov 2022filed 2 Dec 2022CRVO CervoMedBiotechnologySEC FORM 4 Code M—183filing
30 Nov 2022filed 2 Dec 2022CRVO CervoMedBiotechnologySEC FORM 4 Code D—68filing
31 Aug 2022filed 2 Sep 2022CRVO CervoMedoption or derivative · BiotechnologySEC FORM 4 Code M—183 at $0.00filing
31 Aug 2022filed 2 Sep 2022CRVO CervoMedBiotechnologySEC FORM 4 Code M—183filing
31 Aug 2022filed 2 Sep 2022CRVO CervoMedBiotechnologySEC FORM 4 Code D—67filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.